PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech’s Covid vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech’s COVID-19 vaccine. “We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We’ve 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” said Dr OP Kalra, vice-chancellor, PGI Rohtak. Kalra also informed that in the phase-2 trial, they have recruited volunteers who have controlled diabetes and high blood pressure. Watch the full video for more details.
Connect with Hindustan Times
Press the bell icon on YouTube for all the latest updates from Hindustan Times
Like us on Facebook:
Tweet us on Twitter:

Source : Hindustan Times

Disclaimer: This NEWS post has been auto-published from an media agency feed without any modifications to the text. It has not been reviewed by an editor.

Leave a Reply

Your email address will not be published. Required fields are marked *